BofA-ML raises target price for Tata Motors by 26% to Rs 360

BofA-ML raises target price for Tata Motors by 26% to Rs 360

Bank of America Merrill Lynch raised its target price for Tata Motors stock by 26 per cent to Rs 360, and upgraded the stock from `neutral' to `buy', thanks to the strong performance by the auto giant's luxury brand Jaguar Land Rover (JLR) in 2012.

Among the 30-share SENSEX stocks, Tata Motors was the best performer in 2012. According to the recently released figures, Tata Motors sold a total of 47,515 commercial vehicles, 37,649 light commercial vehicles and 9,866 medium & heavy commercial vehicles in December.

In November, JLR's global sales increased 14 per cent year-on-year to 29,893 units.

The company's November sales increased in almost every major market, with sales growing in China, Asia-pacific, Europe and the UK by 43 per cent, 26 per cent, 12 per cent and 15 per cent, respectively.

Bank of America Merrill Lynch expects a hike in profit forecasts by 15 per cent to 25 per cent on better sales mix.

Almost all major car manufacturers in India either reported a decline or a marginal hike in December car sales, in spite of offering heavy year-end discounts. Toyota Kirloskar Motors, Hyundai Motors and General Motors reported a drop in sales, mainly due to high interest rates, spiraling inflation and soaring fuel prices.


Tagged with

Miscellaneous

Tata Sons cancels stake sale in TTML

Tata Sons cancels stake sale in TTML

Tata Sons Ltd on Friday confirmed that its decision to cancel its offer for sale (OFS) of shares in its subsidiary Tata Teleservices (Maharashtra) Ltd.

The OFS was announced on Wednesday, when Tata Sons said that it would sell a total of 51,623,679 shares, or 2.72 per cent of the equity capital of the Tata Teleservices (Maharashtra) Ltd, on May 17.

But, the company yesterday confirmed that it had cancelled the sale. In a filing to the Bombay Stock Exchange (BSE), the company said, "Tata Sons Limited has now informed BSE that they have decided to cancel the sale in full."

Prices of several life-saving drugs to drop by up to 80%

Prices of several life-saving drugs to drop by up to 80%

The prices of several life-saving medicines will soon fall by up to 80 per cent in India, thanks to the government's new drug price control order.

Issued by the union government, the long-pending drug price control order has paved the way for the implementation of pharmaceutical pricing control policy across the country. It is expected to reduce the prices of drugs on an average by 20-25 per cent, and some cancer drugs by up to 80 per cent.